NA

Nazia Anjum

Active Director Director DIN 10110642
DIN 10110642 First appointment Apr 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Nazia Anjum

Data last updated:

Nazia Anjum is a Director at Aelixir Healthcare Private Limited (since 2023). Aelixir Healthcare Private Limited reported revenue of ₹24.4 Lakh (FY 2025).

DIN 10110642
Primary Designation Director
First Appointment 11 Apr 2023
Oldest Company Age 3 yrs
Largest company Aelixir Healthcare Private Limited · ₹24.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aelixir Healthcare Private Limited U47721TS2023PTC171824
Director11 Apr 20232023₹24.4 Lakh (FY 2025)Active

Board colleagues of Nazia Anjum

NameDINCompanyDesignation
Mohammed Ateeq Ahmed10110641Aelixir Healthcare Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Aelixir Healthcare Private Limited
Premium access

Shareholding and investment profile for Nazia Anjum

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nazia Anjum

Nazia Anjum currently holds 1 directorship: Aelixir Healthcare Private Limited (Director, since 11 Apr 2023, revenue ₹24.4 Lakh (FY 2025)).

Nazia Anjum was first appointed on 11 Apr 2023 as Director at Aelixir Healthcare Private Limited.

The current boards of Nazia Anjum's companies include Mohammed Ateeq Ahmed (Aelixir Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available